Nanobiotix S.A. provides Q3 Operational and Financial Update
Source: SeekingAlpha
2025-11-24 16:22:24 ET
More on Nanobiotix
- Nanobiotix S.A.: Behind The Recent Momentum
- Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case
- Nanobiotix S.A. (NBTX) Discusses on New Phase 1 Results In Metastatic Melanoma Conference
- Nanobiotix gains after early-stage trial data for J&J-partnered cancer drug
- Nanobiotix soars on positive phase 1 results for JNJ-1900 in melanoma
Read the full article on Seeking Alpha
For further details see:
Nanobiotix S.A. provides Q3 Operational and Financial Update
Nanobiotix S.A.
NASDAQ: NBTX
NBTX Trading
-12.05% G/L:
$33.95 Last:
66,562 Volume:
$36.54 Open:
NBTX Latest News
November 24, 2025 04:15:00 pm
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
November 24, 2025 10:29:00 am
Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue
NBTX Stock Data
$1,242,583,496
29,172,256
N/A
4
N/A
Biotechnology & Life Sciences
Healthcare
FR
Paris
